Some years ago, incidental observations provided the basis for a new therapeutical approach in the field of cancer research: Following an infection with cowpox or rabies, cancer patients went into short-term remission. Subsequently, various types of viruses were tested against diverse tumors in clinical trials. These so-called “oncolytical viruses” are regarded as a novel kind of cancer therapy in which viruses infect and destroy the tumor cells. Yuan Song Biotechnology is a company engaged in viral therapy research. For its sensitive substance that is filled in vials, the Chinese pharmaceutical company needed a marking and documentation label. Schreiner MediPharm offered an ideal solution in the form of its Pharma-Comb IL Label.

One of the challenges during the label development for the unit dose vial was temperature stability because the sensitive active ingredients have to be stored and transported at minus 20 till minus 70 degrees Celsius and thawed prior to dispensing. The label has to reliably adhere to the vial at all times during this process. Healthcare professionals can check if the drug is flawless and the liquid is clear by means of a label-integrated transparent inspection window. As another key criterion, the label has to offer ample space for the most important information and include two detachable labels for documenting the medication administration in the patient and hospital files for the clinical trial.

The Pharma-Comb IL Label with detachable labels developed by Schreiner MediPharm convinced Yuan Song especially in terms of its multifunctionality and the temperature stability of the material and adhesive. It supports reliable and clear product marking from storage and transportation through to dispensing. The detachable labels have tabs for convenient handling and thus facilitate reliable documentation during the clinical trial.